Showing results (61-70 of 141) with videos related to
Sort By:
Pageof 15
Digestive Diseases and Sciences|December 1, 2019
Patients over Age 75 Are at Increased Risk of Emergency Department Visit and Hospitalization Following ColonoscopyLaurie B Grossberg, Konstantinos Papamichael, Daniel A Leffler, et al.Clinical Immunology (Orlando, Fla.)|March 31, 2018
Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAg-) on anti-TNF therapy have a low rate of reactivationWilliam T Clarke, Shreya S Amin, Konstantinos Papamichael, et al.Scandinavian Journal of Gastroenterology|July 6, 2026
Assessing trial eligibility and real-world response to vedolizumab and ustekinumab in patients with ulcerative colitisStephen Le Breton, Aditya Mithal, Tasnim Ahmed, et al.Clinical Immunology (Orlando, Fla.)|March 17, 2018
Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapiesKonstantinos H Katsanos, Konstantinos Papamichael, Joseph D Feuerstein, et al.Chemotherapy|September 30, 2006
Autoimmune cholangitis presented as fever of unknown originConstantinos Petrogiannopoulos, Konstantinos Papamichael, Georgios Karachalios, et al.Annals of Gastroenterology|October 2, 2015
Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelinesGerassimos J Mantzaris, Nikos Viazis, Dimitris Polymeros, et al.Journal of Bone and Mineral Metabolism|June 24, 2009
The effects of recombinant human TSH on bone turnover in patients after thyroidectomyHelen Karga, Garyphallia Papaioannou, Antonis Polymeris, et al.Annals of Gastroenterology|April 10, 2014
Association of TNF and FcγRΙΙΙA gene polymorphisms with differential response to infliximab in a Greek cohort of Crohn's disease patientsKonstantinos Papamichael, Maria Gazouli, Christos Karakoidas, et al.Gastrointestinal Endoscopy|September 2, 2017
Predictors of post-colonoscopy emergency department useLaurie B Grossberg, Alina Vodonos, Konstantinos Papamichael, et al.Journal of Crohn'S & Colitis|March 29, 2018
Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel DiseaseKonstantinos Papamichael, Ravy K Vajravelu, Byron P Vaughn, et al.Pageof 15